LakeShore Biopharma
LSB
#8131
Rank
NZ$0.23 B
Marketcap
$1.20
Share price
-4.49%
Change (1 day)
-18.11%
Change (1 year)

Revenue for LakeShore Biopharma (LSB)

Revenue in 2023 (TTM): NZ$0.15 B

According to LakeShore Biopharma's latest financial reports the company's current revenue (TTM) is NZ$0.15 B. an increase over the revenue in the year 2022 that were of NZ$0.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for LakeShore Biopharma from 2021 to 2023

Annual revenue

Year Revenue Change
2023 NZ$0.16 B26.21%
2022 NZ$0.12 B102.62%
2021NZ$63.22 M